Endogenous	O
thyroid	O
hormones	O
modulate	O
pituitary	B-Cell
somatotroph	I-Cell
differentiation	O
during	O
chicken	O
embryonic	B-Developing_anatomical_structure
development	O
.	O

Growth	O
hormone	O
cell	B-Cell
differentiation	O
normally	O
occurs	O
between	O
day	O
14	O
and	O
day	O
16	O
of	O
chicken	O
embryonic	B-Developing_anatomical_structure
development	O
.	O

We	O
reported	O
previously	O
that	O
corticosterone	O
(	O
CORT	O
)	O
could	O
induce	O
somatotroph	B-Cell
differentiation	O
in	O
vitro	O
and	O
in	O
vivo	O
and	O
that	O
thyroid	O
hormones	O
could	O
act	O
in	O
combination	O
with	O
CORT	O
to	O
further	O
augment	O
the	O
abundance	O
of	O
somatotrophs	B-Cell
in	O
vitro	O
.	O

The	O
objective	O
of	O
the	O
present	O
study	O
was	O
to	O
test	O
our	O
hypothesis	O
that	O
endogenous	O
thyroid	O
hormones	O
regulate	O
the	O
abundance	O
of	O
somatotrophs	B-Cell
during	O
chicken	O
embryonic	B-Developing_anatomical_structure
development	O
.	O

Plasma	B-Organism_substance
samples	I-Organism_substance
were	O
collected	O
on	O
embryonic	B-Developing_anatomical_structure
day	O
(	O
e	O
)	O
9	O
-	O
14	O
.	O

We	O
found	O
that	O
plasma	B-Organism_substance
CORT	O
and	O
thyroid	O
hormone	O
levels	O
increased	O
progressively	O
in	O
mid	O
-	O
embryogenesis	O
to	O
e	O
13	O
or	O
e	O
14	O
,	O
immediately	O
before	O
normal	O
somatotroph	B-Cell
differentiation	O
.	O

Administration	O
of	O
thyroxine	O
(	O
T4	O
)	O
and	O
triiodothyronine	O
(	O
T3	O
)	O
into	O
the	O
albumen	B-Organism_substance
of	O
fertile	B-Developing_anatomical_structure
eggs	I-Developing_anatomical_structure
on	O
e	O
11	O
increased	O
somatotroph	B-Cell
proportions	O
prematurely	O
on	O
e	O
13	O
in	O
the	O
developing	O
chick	O
embryos	B-Developing_anatomical_structure
in	O
vivo	O
.	O

Furthermore	O
,	O
administration	O
of	O
methimazole	O
,	O
the	O
thyroid	O
hormone	O
synthesis	O
inhibitor	O
,	O
on	O
e	O
9	O
inhibited	O
somatotroph	B-Cell
differentiation	O
in	O
vivo	O
,	O
as	O
assessed	O
on	O
e	O
14	O
;	O
this	O
suppression	O
was	O
completely	O
reversed	O
by	O
T3	O
replacement	O
on	O
e	O
11	O
.	O

Since	O
we	O
reported	O
that	O
T3	O
alone	O
was	O
ineffective	O
in	O
vitro	O
,	O
we	O
interpret	O
these	O
findings	O
to	O
indicate	O
that	O
the	O
effects	O
of	O
treatments	O
in	O
vivo	O
were	O
due	O
to	O
interactions	O
with	O
endogenous	O
glucocorticoids	O
.	O

These	O
results	O
indicate	O
that	O
treatment	O
with	O
exogenous	O
thyroid	O
hormones	O
can	O
modulate	O
somatotroph	B-Cell
abundance	O
and	O
that	O
endogenous	O
thyroid	O
hormone	O
synthesis	O
likely	O
contributes	O
to	O
normal	O
somatotroph	B-Cell
differentiation	O
.	O

